期刊文献+

口腔粘膜下纤维性变组织中转化生长因子β_1mRNA表达水平 被引量:6

The mRNA Expression of Transforming Growth Factorβ_1 in Oral Submucous Fibrosis Tissues──In Situ Hybridization Study
下载PDF
导出
摘要 应用地高辛标记探针的原位杂交技术对25例口腔粘膜下纤维性变(OSF),5例口腔扁平苔藓(OLP),5例正常口腔粘膜(NOR)石蜡标本组织中转化生长因子β1(TGFβ1)mRNA进行了检测。结果显示:15例(15/25,60%)OSF组织中有TGFβ1mRNA表达,而5例OLP及5例NOR组织中均为阴性表达。8例初、早期OSF组织中,有7例(87.5%)TGFβ1mRNA表达呈阳性,而17例中、晚期OSF组织中,只有8例(47.0%)组织中TGFβ1mRNA表达呈阳性,两组间之异有显著性(P=0.0262,α=0.05)。本研究结果提示:转化生长因子β1在OSF的发病机理中可能起重要作用,转化生长因子β1可能是作为一中间介质参与OSF纤维化过程。 The transformin growth factorβ1(TGFβ1)mRNA in the paraffin-embeded tissues of 25 cases of Oral submucous fibrosis(OSF), 5 cases of oral lichen planus(OLP) and 5 cases of normal oral mucous(NOR) was determined by the in situ hybridization technique with a digox labeled probe. The result showed that there were expressions of TGFβ1 mRNA in the 15 OSF tissues(60%), while no positive results were obtained in the tissues of 5 OLP and 5 NOR. The authors divided the 25 OSF into two groups according to the course of the disease. 7 out of the 8 cases of early stage OSF(87.5%)had a positive result of TGFβ1 mRNA expression, out of the 17 cases of advanced stage OSF, however,8 cases(47.0%)showed positive. The difference of TGFβ1mRNA expression between the two groups was significant (p=0.0262 α=0.05). The study suggests that TGFβ1 may play an important role in the pathogenesis of OSF.The TGFβ1mRNA expression level is high during the early stage and declines gradually as the disease develops. It shows that TGFβ1may participates as a mediator in the fibrotic process of OSF.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 1996年第1期20-22,共3页 West China Journal of Stomatology
关键词 口腔粘膜 纤维性变 转化生长因子Β RRNA oral submucous fibrosis transforming growth factorβ_1 in situ hybridization
  • 相关文献

参考文献3

  • 1高义军,国外医学口腔医学分册,1995年,22卷,1期,31页
  • 2秦建中,国外医学皮肤性病学分册,1995年,21卷,9页
  • 3郑麟蕃,口腔病理学,1994年

同被引文献40

  • 1林秀芬.中药丹参药理的研究进展[J].天津医科大学学报,2004,10(S1):60-62. 被引量:42
  • 2高义军,凌天牖.口腔黏膜下纤维性变发病机制的研究进展[J].临床口腔医学杂志,2004,20(8):502-504. 被引量:4
  • 3吕如飞,黄国良.丹参注射液对冠心病心绞痛患者异构前列腺素的影响[J].右江医学,2004,32(3):211-212. 被引量:7
  • 4何洪静,练生利,李惠兰,张荣平.滇丹参提取液对心肌缺血大鼠血液流变性的影响[J].西南国防医药,2005,15(5):465-467. 被引量:13
  • 5Mehrotra D,Pradhan R,Gupta S.Retrospective comparison of surgical treatment modalities in 100 patients with oral submucous fibrosis[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2009,107(3):e1-e10.
  • 6Li P,Wang G J,Li J,et al.Simultaneous determination of tanshinone IIA and its three hydroxylatedmetabolites by liquid chromatography/tandem mass spectrometry[J].Rapid CommunMass Spectrom,2006,20(5):815-822.
  • 7IARC Working Group on the Evaluation of CarcinogenicRisks to Humans.Betel-quid and areca-nut chewing andsome areca-nut derived nitrosamines[J].IARC MonogrEval Carcinog Risks Hum,2004,85:1-334.
  • 8Liu Y,Rajur K,Tilbert E,et al.Endogenous hepatocytegrowth factor ameliorates chronic renal injury by activatingmatrix degradation pathways[J].Kidney Int,2000,58(5):2028-2043.
  • 9Grierson I,Heathcote L,Hiscott P,et al.Hepatocyte growthfactor/scatter factor in the eye[J].Prog Retin Eye Res,2000,19(6):779-802.
  • 10Nakagami H,Morishita R,Yamamoto K,et al.Hepatocytegrowth factor prevents endothelial cell death through inhibi-tion of bax translocation from cytosol to mitochondrial mem-brane[J].Diabetes,2002,51(8):2604-2611.

引证文献6

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部